1008-74-8

Basic information

• Product Name: Isoxazole, 5-methyl-3-phenyl- (7CI,8CI,9CI)
• Synonyms: Isoxazole, 5-methyl-3-phenyl- (7CI,8CI,9CI)
• CAS NO: 1008-74-8
• Molecular Formula: C₁₀H₉NO
• Molecular Weight: 159.18456
• Product Categories: OXAZOLE
• Mol File: 1008-74-8.mol
• Article Data: 41

Chemical Properties

• Boiling Point: 282.7 °C at 760 mmHg
• Flash Point: 115.3 °C
• Appearance: /
• Density: 1.082 g/cm³
• Vapor Pressure: 0.00566mmHg at 25°C
• Refractive Index: 1.539
• CAS DataBase Reference: Isoxazole, 5-methyl-3-phenyl- (7CI,8CI,9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Isoxazole, 5-methyl-3-phenyl- (7CI,8CI,9CI)(1008-74-8)
• EPA Substance Registry System: Isoxazole, 5-methyl-3-phenyl- (7CI,8CI,9CI)(1008-74-8)

Safety Data

• Hazardous Substances Data: 1008-74-8(Hazardous Substances Data)

Usage

General Description

Isoxazole, 5-methyl-3-phenyl- (7CI,8CI,9CI) is a chemical compound with the molecular formula C10H9NO. It is a type of isoxazole, which is a heterocyclic compound containing an oxygen and nitrogen atom in a five-membered ring. The 5-methyl-3-phenyl structure refers to the specific arrangement of atoms within the compound. This chemical is commonly used in the pharmaceutical and agrochemical industries due to its potential biological activity and ability to act as a building block for the synthesis of various organic compounds. It may also have other industrial applications due to its structural and chemical properties.

InChI:InChI=1/C10H9NO/c1-8-7-10(11-12-8)9-5-3-2-4-6-9/h2-7H,1H3

Upstream product

• 53120-17-5 1-phenyl-1,3-pentanedionedioxime 
• 1817-57-8 4-phenyl-3-butyne-2-one 
• 93-91-4 1-phenylbutan-1,3-dione 
• 22965-93-1 (Z)-2-Bromo-1-phenyl-2-butyn-1-one 
• 106808-15-5 3-phenyl-5-<(phenylsulfonyl)methyl>isoxazole 
• 75624-77-0 Triphenyl(3-phenyl-5-isoxazolylmethyl)phosphonium-chlorid 
• 7803-49-8 hydroxylamine 
• 77252-92-7 3-ethoxy-1-phenyl-but-2-en-1-one 
• 42392-88-1 1-phenyl-3-methoxybut-2-en-1-one 
• 60-29-7 diethyl ether 
• 1027564-45-9 5-hydroxy-5-methyl-3-phenyl-4,5-dihydro-2-isoxazole 
• 116-11-0 2-Methoxypropene 
• 698-16-8 benzohydroximoyl chloride 
• 873-67-6 benzonitrile oxide 

Downstream Products

• 62679-05-4 5-methylsulfanylmethyl-3-phenyl-isoxazole 
• 3919-84-4 2-(3-phenylisoxazol-5-yl)acetic acid 
• 57354-90-2 5-methyl-3-phenyl-4-nitroisoxazole 
• 80949-40-2 4,4-Dichloro-5-methoxy-5-methyl-3-phenyl-4,5-dihydro-isoxazole 
• 139193-82-1 5-[(E)-2-(2-Methoxy-phenyl)-vinyl]-3-phenyl-isoxazole 
• 1441-42-5 3-phenyl-5-styrylisoxazole 
• 156088-10-7 3-phenyl-5-(tert-butyldimethylsilyl)methylisoxazole 
• 139193-97-8 Dimethyl-{4-[(E)-2-(3-phenyl-isoxazol-5-yl)-vinyl]-phenyl}-amine 
• 69209-40-1 methyl 2-methyl-6-phenylpyridine-4-carboxylate 
• 6237-59-8 hexamethyl benzenehexacarboxylate 
• 87444-85-7 3,4-bis(methoxycarbonyl)-2-methyl-6-phenylpyridine 
• 79344-02-8 3-phenyl-4,4-dichloro-5-methyl-5-hydroxy-Δ²-isoxaline 
• 94225-41-9 (Z)-5-<2-(tert-butyldimethylsilyl)amino-2-phenylvinyl>-3-phenylisoxazole 
• 96603-34-8 5-Methanesulfinylmethyl-3-phenyl-isoxazole 

Relevant articles and documents

Structural Investigation of 3,5-Disubstituted Isoxazoles by 1H-Nuclear Magnetic Resonance

HIV-1 integrase (IN) is a very promising and validated target for the development of therapeutic agents against AIDS. In an effort to design and synthesize biological isosteric analogs of β-diketoacid-containing inhibitors of IN, we prepared a series of s

Dehydrochlorination of Hydroximoyl Chlorides by the Use of Vinyltins for Synthesis of Isoxazolines (Dihydrooxazoles)

The reaction of hydroximoyl chlorides and vinyltin compounds afforded isoxazolines via dehydrochlorination and dipolar cycloaddition.

Hexacarbonylmolybdenum-induced Reaction of Isoxazoles. Cycloaddition of Isoxazoles with Acetylenic Esters and Related Reactions

In the presence of hexacarbonylmolybdenum, substituted isoxazoles undergo a cycloaddition reaction with dimethyl acetylenedicarboxylate across the C-4-C-5 bond to give 3,4-bis(methoxycarbonyl)pyridine derivatives.In a similar cycloadition of isoxazoles with methyl propiolate, 4-(methoxycarbonyl)pyridine derivatives were also obtained.The β-carbon atom of methyl propiolate could intervene in the bonding with the C-5 position of the isoxazoles regioselectively.A mechanism involving a complexed 2-oxa-3-azabicyclohepta-3,6-diene derivative and the subsequent N-Oand C-1-C-5 bond cleavage leading to a complexed (β-ketovinyl)nitrene intermediate is proposed for the formation of pyridine derivatives.In order to clarify the mechanistic aspect, the reaction of 4-phenyl-2-oxa-3-azabicyclohepta-3,6-diene and its related compounds were also studied to give pyridine derivatives.

Asymmetric Aza-Diels-Alder Reactions of in Situ Generated β,β-Disubstituted α,β-Unsaturated N-H Ketimines Catalyzed by Chiral Phosphoric Acids

A novel asymmetric synthesis of dihydropyridinones with vicinal quaternary stereocenters has been realized by asymmetric aza-Diels-Alder reactions of 3-amido allylic alcohols with oxazolones enabled by chiral phosphoric acid catalysis. A series of aryl/alkyl- and alkyl/alkyl-disubstituted 3-amido allylic tertiary alcohols and 4-substituted oxazolones could be well tolerated in these reactions, producing dihydropyridinones with excellent diastereoselectivities and high enantioselectivities. Mechanistic study and control experiments were performed to shed light on the reaction mechanism, in which a configurationally defined β,β-disubstituted α,β-unsaturated N-H ketimine was proposed as the key intermediate.

AMINOPEPTIDASE A INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

The present invention relates to a novel compound, to a composition comprising the same, to methods for preparing the compound, and the use of this compound in therapy. In particular, the present invention relates to compound that is useful in the treatment and prevention of primary and secondary arterial hypertension, ictus, myocardial ischaemia, cardiac and renal insufficiency, myocardial infarction, peripheral vascular disease, diabetic proteinuria, Syndrome X and glaucoma.